We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




DNA Sequencing Technologies Help Diagnosis of Salmonella typhi

By Labmedica staff writers
Posted on 04 Aug 2008
Researchers have used next-generation DNA sequencing technologies to type Salmonella typhi (Salmonella enterica serotype Typhi, elevated to species status as S. More...
typhi), identify the strain that causes infection, identify carriers, and direct vaccination programs more efficiently. This will help to improve diagnosis, tracking of disease spread, and possibly the design of new strategies for vaccination.

Unlike most related Salmonella species, and in contrast to many other bacteria, S. typhi is found only in humans and the genomes of all isolates are superficially extremely similar, hampering attempts to track infections or to type more prevalent variants. There are 17 million cases of typhoid fever each year--although the World Health Organization (WHO; Geneva, Switzerland; www.who.org) cautions that this is a "very conservative” estimate. Young people are most at risk: in Indonesia, 9 out of 10 cases occur in 3 to 19-year-olds.

A team of researchers at the Wellcome Trust Sanger Institute (Cambridge, UK), University College, Cork (UCC; UK), Institut Pasteur (Paris, France), and Oxford University Clinical Research Unit (Ho Chi Minh City, Vietnam) studied 19 isolates of Typhi from 10 countries, using new sequencing methods in order to capture the rare signals of genetic variation in the genome. They produced more than 1.7 billion letters of genetic sequence and found evidence of fewer than 2000 mutation events, suggesting very little evolution since the emergence of Typhi at least 15,000 years ago.

The team developed methods that are being used to type outbreaks, allowing identification of individual organisms that are spreading in the population "A key to survival of S. typhi is its ability to lie dormant in carriers, who show no symptoms but remain able to infect others,” said Kathryn Holt, a Ph.D. student at the Wellcome Trust Sanger Institute. "Our new tools will assist us in tracing the source of typhoid outbreaks, potentially even to infected carriers, allowing those individuals to be treated to prevent further spread of the disease.”

The study was reported in the June 27, 2008, issue of the journal Nature Genetics.


Related Links:
Wellcome Trust Sanger Institute
University College, Cork
World Health Organization

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.